985-629-5825
849 Galvez St.
Mandeville, La 70448
PDF PRESENTATIONS
MTHFR Presentation
This presentation provides an in-depth overview of MTHFR polymorphism, its connection to psychiatric disorders, and a natural treatment approach using EnLyte. It begins with the basics of MTHFR polymorphism and other methylation gene polymorphisms, explaining how these genetic variations affect folate metabolism and its implications for mental health. The presentation looks into the role of MTHFR in psychiatric conditions such as depression, highlighting the importance of addressing this underlying issue. Finally, it introduces EnLyte as a natural, clinically proven option for patients with MTHFR polymorphism.
MDD/ADHD Comorbidity Presentation
"The natural complement to drug stimulants for managing ADHD" presentation explores EnLyte as an evidence-based, all-natural adjunctive treatment option for ADHD and the complete symptom complex. While current ADHD medications primarily target attention and focus, they often overlook critical aspects such as emotional dysregulation and associated psychiatric comorbidities. The presentation highlights how EnLyte addresses these gaps by providing a comprehensive approach that supports mental health beyond traditional ADHD treatments.
_Page_1.jpg)
Treatment Innovations in Women's Mental Health Presentation
"Treatment Innovations in Women's Mental Health," highlights the unique approach of EnLyte in addressing the specific mental health needs of women. EnLyte, along with EnBrace HR, has been clinically proven to be effective in treating Major Depressive Disorder (MDD), offering significant benefits for women. The presentation explores how these products support women experiencing Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), and the challenges associated with menopause. Additionally, EnBrace HR is emphasized for its safety and effectiveness in and around pregnancy, making it a vital option for women during these critical periods. across various stages of life.
Innovations in Women's Mental & Reproductive Health Presentation
This presentation, similar to "Treatment Innovations in Women's Mental Health," focuses on pregnancy, and explores how EnLyte can be safely used in women who are pregnant or planning to become pregnant. EnLyte offers an effective alternative to traditional antidepressants for women seeking to avoid medication during pregnancy to prioritize the safety of the fetus.
EnLyte / EnBrace HR Presentation
In this presentation, we will explore the vital role of methylation in mental health, focusing on how folate deficiency and MTHFR polymorphisms affect psychiatric conditions. Attendees will learn about the causes of folate deficiency and the impact of methylation imbalances.
We will also review APA guidelines for using folate in psychiatric care and highlight clinical trials showing EnLyte's effectiveness in treating Major Depressive Disorder. Additionally, we will examine EnLyte's key ingredients, their biochemical functions, and practical guidance on prescribing it for mental health management.
